{{ define "extra_styles" }}
<!-- Plugin CSS -->
<link href="vendor/magnific-popup/magnific-popup.css" rel="stylesheet">
{{ end }}

{{ define "extra_scripts" }}
<!-- Plugin JavaScript-->
<script src="vendor/jquery-easing/jquery.easing.min.js"></script>
<!-- Custom scripts for this template -->
<script src="js/creative.js"></script>
{{ end }}

{{ define "main" }}
<!--Navigation -->
<nav class="navbar navbar-expand-lg navbar-dark fixed-top" id="mainNav">
    <div class="container">
        <a class="navbar-brand js-scroll-trigger" href="#page-top"><span class="fa fa-home"></span></a>
        <button aria-controls="navbarResponsive" aria-expanded="false" aria-label="Toggle navigation" class="navbar-toggler" data-target="#navbarResponsive" data-toggle="collapse" type="button">
            <span class="navbar-toggler-icon"></span>
        </button>

        <div class="collapse navbar-collapse" id="navbarResponsive">
            <ul class="navbar-nav ml-auto">
                <li class="nav-item">
                    <a class="nav-link js-scroll-trigger" href="#about">About</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link js-scroll-trigger" href="#requests">Requests</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link js-scroll-trigger" href="#compounds">Compounds</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link js-scroll-trigger" href="#models">Genetic Models</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link js-scroll-trigger" href="#contact">Project Team</a>
                </li>
            </ul>
        </div>
    </div>
</nav>
<header class="masthead">
    <div class="header-content">
        <div class="header-content-inner">
            <h1 id="homeHeading">Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance</h1>
            <hr>
            <p>Project resource website for DK099810 and DK114785</p><a class="btn btn-primary btn-xl js-scroll-trigger" href="#about">Learn more</a>
        </div>
    </div>
</header>
<section class="bg-primary" id="about">
    <div class="container">
        <div class="row">
            <div class="col-lg-8 mx-auto text-center">
                <h2 class="section-heading">Our goal</h2>
                <hr>
                <p class="text-faded">There is a need to develop drugs for metabolic disease with a mechanism of action distinct from that of existing agents. This project combines expertise from multiple scientific fields (chemical proteomics, medicinal
                    chemistry, adipose tissue and liver biology, lipid metabolism) to discover and characterize new molecular pathways that can be targeted pharmacologically to revert obesity-linked adipocyte defects that drive systemic insulin resistance and
                    type 2 diabetes.</p>

                <p>We aim to identify in tandem physiologically relevant proteins and chemical tools to perturb the function of these proteins to expedite their functional annotation and therapeutic validation. In the process, <em>we are creating
                        first-in-class chemical probes and genetic models to study key metabolic pathways that we are happy to share with the larger research community</em>.</p> <a class="btn btn-default btn-xl js-scroll-trigger" href="#compounds">Compounds</a> <a
                    class="btn btn-default btn-xl js-scroll-trigger" href="#models">Genetic Models</a>
            </div>
        </div>
    </div>
</section>

<section id="requests">
    <div class="container">
        <div class="row">
            <div class="col-lg-8 mx-auto text-center">
                <h2 class="section-heading">Requests for materials</h2>
                <hr>
                <p class="text-faded">We are happy to discuss requests for reagents and are committed to providing reasonable quantities at no cost beyond nominal charges for shipping of materials. Please fill out a <a href="./material_request_form.html"
                        target="_blank">Material Request Form</a> and e-mail it to <a href="mailto:rc2requests@scripps.edu">rc2requests@scripps.edu</a>. We will process your request and respond with a Material Transfer Agreement (MTA). After receiving your completed
                    MTA, we will send the requested materials.</p>
                <p>Please send any other questions or feedback to <a href="mailto:rc2requests@scripps.edu">rc2requests@scripps.edu</a>.</p>
                <a class="btn btn-default btn-xl" href="./material_request_form.html" target="_blank">Material Request Form</a>
            </div>
        </div>
    </div>
</section>

<section id="compounds">
    <div class="container">
        <div class="row">
            <div class="col-lg-12 text-center">
                <h2 class="section-heading">Compounds Developed</h2>
                <hr class="primary">
                <div class="panel-group" id="accordion">

                    <!--ces3-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse1">CES3 <span class="non_caps">(Ces1d)</span></a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse1">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="wwl113"><img alt="WWL113" class="wide" src="img/structures/WWL113.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>WWL113</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/17759482" target="_blank">17759482</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>947669-86-5</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>ethyl 4'-((methyl(3-(pyridin-4-yl)benzyl)carbamoyl)oxy)-[1,1'-biphenyl]-4-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>466.54</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.sigmaaldrich.com/catalog/product/sigma/sml1179" target="_blank">Sigma</a> <a href="https://www.caymanchem.com/product/16181" target="_blank">Cayman</a> <a href="https://www.tocris.com/products/wwl-113_5259" target="_blank">Tocris</a>
                                                    <a href="https://www.trc-canada.com/product-detail/?W700000" target="_blank">TRC</a> <a href="https://www.aurumpharmatech.com/Product/ProductDetails?id=CX7107" target="_blank">Aurum Pharmatech</a> <a href="http://online.aurorafinechemicals.com/info?ID=A24.551.880"
                                                        target="_blank">Aurora</a> <a href="https://aksci.com/item_detail.php?cat=SYN5248" target="_blank">AkSci</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>WWL113 is a potent, in vivo active, covalent inhibitor of mouse Ces3 (Ces1d) and Ces1f. It inhibits Ces3 and Ces1f recombinantly expressed in HEK293T cells (IC50 ~ 0.1 &micro;M). It is also a potent inhibitor of human CES1 (IC50 =
                                                        46 nM), the homolog of mouse Ces3, in synthetic substrate hydrolysis assays. WWL113 promotes adipocyte differentiation and lipid storage in mouse 3T3-L1 and 10T1/2 preadipocytes. Treatment with WWL113 blocks basal lipolysis in mature
                                                        adipocytes. In C57Bl/6 mice, a single 30 mg⋅kg<sup>−1</sup> oral dose of WWL113 blocks >90% of liver and >75% of white adipose tissue Ces3 activity within 4 h. Chronic treatment of obese-diabetic <em>db</em>/<em>db</em> (30 mg⋅kg<sup>−1</sup>)
                                                        or Diet Induced Obese (50 mg⋅kg<sup>−1</sup>) mice resulted in weight loss, normalization of plasma glucose and lipid profiles, improved glucose tolerance, increased insulin sensitivity, and a complete clearance of liver ectopic lipid
                                                        deposits.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K. L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., O'Brien, P. E., Russell, A. P., Watt, M. J., Nomura, D. K., Cravatt, B. F., and Saez, E.
                                                            (2014) Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes, Nat. Chem. Biol. 10, 113-121.
                                                            <a target="_blank" href="https://doi.org/10.1038/nchembio.1429">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/24362705">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="wwl113u"><img alt="WWL113U" class="wide" src="img/structures/WWL113U.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>WWL113U</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for <a href="#wwl113" class="js-scroll-trigger">WWL113</a></td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/72183489" target="_blank">72183489</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1528560-36-2</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>ethyl 4'-(3-methyl-3-(3-(pyridin-4-yl)benzyl)ureido)-[1,1'-biphenyl]-4-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>465.21</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=WWL113U" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>WWL113U is a structurally related control compound for <a href="#wwl113" class="js-scroll-trigger">WWL113</a>. Substitution of the carbamate group with a urea group renders WWL113U unable to inhibit Ces3 or Ces1f. WWL113U does not
                                                        promote differentiation of preadipocytes or inhibit basal lipolysis in mature adipocytes. It also does not inhibit human CES1, the homolog of mouse Ces3.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K. L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., O'Brien, P. E., Russell, A. P., Watt, M. J., Nomura, D. K., Cravatt, B. F., and Saez, E.
                                                            (2014) Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes, Nat. Chem. Biol. 10, 113-121.
                                                            <a target="_blank" href="https://doi.org/10.1038/nchembio.1429">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/24362705">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="wwl229"><img alt="WWL229" class="tall" src="img/structures/WWL229.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>WWL229</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/72183487" target="_blank">72183487</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1338575-28-2</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>4-nitrophenyl 2-(2-acetamidoethyl)piperidine-1-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>322.15</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.sigmaaldrich.com/catalog/product/sigma/sml1180" target="_blank">Sigma</a> <a href="https://www.caymanchem.com/product/16182" target="_blank">Cayman</a> <a href="https://www.trc-canada.com/product-detail/?W700500"
                                                        target="_blank">TRC</a> <a href="https://www.aurumpharmatech.com/Product/ProductDetails?id=CX7108" target="_blank">Aurum Pharmatech</a> <a href="https://aksci.com/item_detail.php?cat=SYN5249" target="_blank">AK Scientific</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td colspan="2">
                                                    <p>WWL229 is a selective, covalent, carbamate inhibitor of Ces3 structurally distinct from <a href="#wwl113" class="js-scroll-trigger">WWL113</a>. It inhibits Ces3 recombinantly expressed in HEK293T cells (IC50 = ~1.94 μM) but not
                                                        Ces1f (IC50 > 20 μM). It shares with <a href="#wwl113" class="js-scroll-trigger">WWL113</a> the ability to promote differentiation of preadipocytes and inhibit basal lipolysis in mature adipocytes.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K. L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., O'Brien, P. E., Russell, A. P., Watt, M. J., Nomura, D. K., Cravatt, B. F., and Saez, E.
                                                            (2014) Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes, Nat. Chem. Biol. 10, 113-121.
                                                            <a target="_blank" href="https://doi.org/10.1038/nchembio.1429">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/24362705">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="wwl228"><img alt="WWL228" class="tall" src="img/structures/WWL228.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>WWL228</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for <a href="#wwl229" class="js-scroll-trigger">WWL229</a></td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/72183488" target="_blank">72183488</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1338575-27-1</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>4-nitrophenyl 2-(2-acetamidoethyl)piperidine-1-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>335.15</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=WWL228" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td colspan="2">
                                                    <p>WWL228 is a structurally related control compound for <a href="#wwl229" class="js-scroll-trigger">WWL229</a>. It does not inhibit Ces3 or Ces1f recombinantly expressed in HEK293T cells (IC50 > 20 μM). WWL228 does not promote
                                                        differentiation of preadipocytes or inhibit basal lipolysis in mature adipocytes.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K. L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., O'Brien, P. E., Russell, A. P., Watt, M. J., Nomura, D. K., Cravatt, B. F., and Saez, E.
                                                            (2014) Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes, Nat. Chem. Biol. 10, 113-121.
                                                            <a target="_blank" href="https://doi.org/10.1038/nchembio.1429">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/24362705">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />



                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="jw972"><img alt="JW972" class="tall" src="img/structures/JW972.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>JW972</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Activity-based probe</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/72183486" target="_blank">72183486</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1528560-41-9</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>4-nitrophenyl 2-(3-(prop-2-yn-1-yloxy)propyl)piperidine-1-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>346.38</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=JW972" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td colspan="2">
                                                    <p>JW972 is an alkyne-derivatized analog of <a href="#wwl229" class="js-scroll-trigger">WWL229</a> that can be used to selectively measure Ces3 activity. JW972 inhibits Ces3 recombinantly expressed in HEK293T cells (IC50 ~ 1.3 μM) but
                                                        not Ces1f (IC50 > 20 μM).</p>
                                                    <ol class="refs">
                                                        <li class="cite">Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K. L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., O'Brien, P. E., Russell, A. P., Watt, M. J., Nomura, D. K., Cravatt, B. F., and Saez, E.
                                                            (2014) Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes, Nat. Chem. Biol. 10, 113-121.
                                                            <a target="_blank" href="https://doi.org/10.1038/nchembio.1429">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/24362705">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                            </div>
                        </div>
                    </div>

                    <!--ddhd2-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse2">DDHD2</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse2">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="klh45"><img alt="KLH45" class="wide" src="img/structures/KLH45.png" /></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>KLH45</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/126970670" target="_blank">126970670</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1632236-44-2</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>N-cyclohexyl-N-phenethyl-4-(4-(trifluoromethoxy)phenyl)-2H-1,2,3-triazole-2-carboxamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>458.49</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.sigmaaldrich.com/catalog/product/sigma/sml1998" target="_blank">Sigma</a> <a href="https://www.caymanchem.com/product/19889" target="_blank">Cayman</a> <a href="https://www.tocris.com/products/klh-45_5865" target="_blank">Tocris</a>
                                                    <a href="https://www.rndsystems.com/products/klh-45_5865" target="_blank">R&amp;D Systems</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>KLH45 is a potent triazole carbamate inhibitor (IC50 = 1.3 nM) of the brain triacylglyceride (TAG) hydrolase DDHD2. KLH45 is highly selective for DDHD2 over other serine hydrolases but does exhibit cross-reactivity with ABHD6, which
                                                        can be controlled for by <a href="#klh40" class="js-scroll-trigger">KLH40</a>. KLH45 (20 and mg⋅kg<sup>−1</sup>, 4 h) resulted in near complete inhibition of DDHD2 in vivo. Whereas acute treatment (20 mg⋅kg<sup>−1</sup>, 4 h) did not
                                                        result in altered brain TAGs, chronic dosing (20 mg⋅kg<sup>−1</sup> every 12 h, 4 days) caused significant elevation (~1.5 fold) of TAGs in mouse brain.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Inloes, J. M., Hsu, K.-L., Dix, M. M., Viader, A., Masuda, K., Takei, T., Wood, M. R., and Cravatt, B. F. (2014) The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase, Proc.
                                                            Natl. Acad. Sci. U.S.A. 111, 14924-14929. <a href="https://doi.org/10.1073/pnas.1413706111" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/25267624" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="klh40"><img alt="KLH40" class="wide" src="img/structures/KLH40.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>KLH40</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for <a href="#klh45" class="js-scroll-trigger">KLH45</a></td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274141" target="_blank">132274141</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(R)-(3-benzylmorpholino)(4-(4-(trifluoromethoxy)phenyl)-1H-1,2,3-triazol-1-yl)methanone</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>432.40</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=KLH40" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>KLH40 is a control compound for <a href="#klh45" class="js-scroll-trigger">KLH45</a> that reacts with ABHD6 with similar potency as the DDHD2 inhibitor <a href="#klh45" class="js-scroll-trigger">KLH45</a> . KLH40 can be used to
                                                        control for the ABHD6 off-target activity of <a href="#klh45" class="js-scroll-trigger">KLH45</a>, in cells (Neuro2a, IC50 ~ 10 nM) and in mice (20 mg⋅kg<sup>−1</sup>, i.p., every 12 h, 4 days).</p>
                                                    <ol class="refs">
                                                        <li class="cite">Inloes, J. M., Hsu, K.-L., Dix, M. M., Viader, A., Masuda, K., Takei, T., Wood, M. R., and Cravatt, B. F. (2014) The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase, Proc.
                                                            Natl. Acad. Sci. U.S.A. 111, 14924-14929. <a href="https://doi.org/10.1073/pnas.1413706111" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/25267624" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="ht01"><img alt="HT01" class="wide" src="img/structures/HT01.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>HT01</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Activity-based probe</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/60204011" target="_blank">60204011</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1402658-23-4</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>N-(5-(3-(5,5-difluoro-7,9-dimethyl-5H-5l4,6l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-3-yl)propanamido)pentyl)-N-phenethyl-4-(4-(trifluoromethoxy)phenyl)-1H-1,2,3-triazole-1-carboxamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>735.57</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=HT01" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>HT01 is a tailored activity-based probe that covalently reacts with DDHD2 and allows fluorescent gel profiling of native DDHD2 activity (e.g. 10 &micro;M in Neuro2a membrane). HT01 also reacts with a small number of other serine
                                                        hydrolases, including the diacylglycerol lipases DAGL&alpha;/&beta;, some of which are challenging to detect with the more broad-spectrum fluorophosphonate probes.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Inloes, J. M., Hsu, K.-L., Dix, M. M., Viader, A., Masuda, K., Takei, T., Wood, M. R., and Cravatt, B. F. (2014) The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase, Proc.
                                                            Natl. Acad. Sci. U.S.A. 111, 14924-14929. <a href="https://doi.org/10.1073/pnas.1413706111" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/25267624" target="_blank">PubMed</a>
                                                        </li>
                                                        <li class="cite">Hsu, K.-L., Tsuboi, K., Adibekian, A., Pugh, H., Masuda, K., and Cravatt, B. F. (2012) DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses, Nat. Chem. Biol. 8, 999-1007. <a href="https://doi.org/10.1038/nchembio.1105"
                                                                target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/23103940" target="_blank">PubMed</a>
                                                        </li>
                                                        <li class="cite">Hsu, K.-L., Tsuboi, K., Whitby, L. R., Speers, A. E., Pugh, H., Inloes, J., and Cravatt, B. F. (2013) Development and Optimization of Piperidyl-1,2,3-Triazole Ureas as Selective Chemical Probes of Endocannabinoid
                                                            Biosynthesis, J. Med. Chem. 56, 8257-8269. <a href="https://doi.org/10.1021/jm400898x" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/24152245" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="ht02"><img alt="HT02" class="wide" src="img/structures/HT02.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>HT02</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Activity-based probe</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/72712447" target="_blank">72712447</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1402612-70-7</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>N-(5-(5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)pentyl)-N-phenethyl-4-(4-(trifluoromethoxy)phenyl)-1H-1,2,3-triazole-1-carboxamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>687.78</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=HT02" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>HT02 is a biotin analog of <a href="#ht01" class="js-scroll-trigger">HT01</a>, with similar target specificity, and can be used for the selective enrichment of DDHD2.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Hsu, K.-L., Tsuboi, K., Whitby, L. R., Speers, A. E., Pugh, H., Inloes, J., and Cravatt, B. F. (2013) Development and Optimization of Piperidyl-1,2,3-Triazole Ureas as Selective Chemical Probes of Endocannabinoid
                                                            Biosynthesis, J. Med. Chem. 56, 8257-8269. <a href="https://doi.org/10.1021/jm400898x" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/24152245" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />


                            </div>
                        </div>
                    </div>

                    <!-- abhd6-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse3">ABHD6</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse3">
                            <div class="panel-body">

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="do53"><img alt="DO53" class="wide" src="img/structures/DO53.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>DO53</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/129188755" target="_blank">129188755</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1848233-59-9</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>tert-butyl 3-phenyl-4-(4-(4-(trifluoromethoxy)phenyl)-1H-1,2,3-triazole-1-carbonyl)piperazine-1-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>517.51</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=DO53" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>DO53 is a potent, in vivo active, covalent inhibitor of ABHD6, developed to control for the off-targets of DAGL inhibitors (including ABHD6) in vivo. DO53 selectively inhibited brain ABHD6 in mice (~100% inhibition at 10 mg·kg<sup>-1</sup>;
                                                        >90% at 10 mg·kg<sup>-1</sup>; 4 h, i.p.) with almost no discernable off-targets by gel profiling (except PLA2G7 at 10 mg·kg<sup>-1</sup>). At higher doses, DO53 showed cross-reactivity with other serine hydrolases, including (>50%
                                                        inhibition) PAFAH2, ABHD3, ABHD2, CES1C, and PLA2G7.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Ogasawara, D., Deng, H., Viader, A., Baggelaar, M. P., Breman, A., den Dulk, H., van den Nieuwendijk, A. M. C. H., Soethoudt, M., van der Wel, T., Zhou, J., Overkleeft, H. S., Sanchez-Alavez, M., Mori, S., Nguyen, W.,
                                                            Conti, B., Liu, X., Chen, Y., Liu, Q.-s., Cravatt, B. F., and van der Stelt, M. (2016) Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition, Proc. Nat. Acad. Sci. USA 113, 26-33.
                                                            <a href="https://doi.org/10.1073/pnas.1522364112" target="_blank">DOI</a>
                                                            <a href="https://www.ncbi.nlm.nih.gov/pubmed/26668358" target="_blank">PubMed</a>
                                                        </li>
                                                        <li class="cite">Deng, H., Kooijman, S., van den Nieuwendijk, A. M. C. H., Ogasawara, D., van der Wel, T., van Dalen, F., Baggelaar, M. P., Janssen, F. J., van den Berg, R. J. B. H. N., den Dulk, H., Cravatt, B. F., Overkleeft, H. S.,
                                                            Rensen, P. C. N., and van der Stelt, M. (2017) Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding, J. Med. Chem. 60, 428-440.
                                                            <a href="https://doi.org/10.1021/acs.jmedchem.6b01482" target="_blank">DOI</a>
                                                            <a href="https://www.ncbi.nlm.nih.gov/pubmed/27992221" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="kt185"><img alt="KT185" class="wide" src="img/structures/KT185.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>KT185</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/53364498" target="_blank">53364498</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1472640-86-0</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(2-phenylpiperidin-1-yl)(4-(3'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>519.65</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="http://www.sigmaaldrich.com/catalog/product/sigma/sml1249" target="_blank">Sigma</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>KT185 is a second-generation covalent inhibitor of ABHD6&mdash;developed specifically for this purpose&mdash;that shows increased potency and selectivity over previous inhibitors. KT185 is orally bioavailable, inhibiting ABHD6 in
                                                        mouse brain (~100% inhibition at 40 mg·kg<sup>-1</sup>, i.p., 4 h; >70% at 20 mg·kg<sup>-1</sup>) with minimal cross-reactivity (other than CES1). Liver ABHD6 was completely inhibited at lower doses (~5–10 mg·kg<sup>-1</sup>). KT185
                                                        inhibited ABHD6 in the membrane fraction of mouse brain homogenates (100% inhibition at 10 nM, IC50 ~ 1 nM) with no observable serine hydrolase off-targets (up to 1 &micro;M) and in Neuro2a cells (IC50 ~ 0.25 nM).</p>
                                                    <ol class="refs">
                                                        <li class="cite">Hsu, K.-L., Tsuboi, K., Whitby, L. R., Speers, A. E., Pugh, H., Inloes, J., and Cravatt, B. F. (2013) Development and Optimization of Piperidyl-1,2,3-Triazole Ureas as Selective Chemical Probes of Endocannabinoid
                                                            Biosynthesis, J. Med. Chem. 56, 8257-8269.
                                                            <a href="https://doi.org/10.1021/jm400898x" target="_blank">DOI</a>
                                                            <a href="https://www.ncbi.nlm.nih.gov/pubmed/24152245" target="_blank">PubMed</a>
                                                        </li>
                                                        <li class="cite">Hsu, K. L., Tsuboi, K., Chang, J. W., Whitby, L. R., Speers, A. E., Pugh, H., and Cravatt, B. F. (2013) Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors
                                                            of &alpha;/&beta;-hydrolase domain containing 6 (ABHD6), J. Med. Chem. 56, 8270-8279.
                                                            <a href="https://doi.org/10.1021/jm400899c" target="_blank">DOI</a>
                                                            <a href="https://www.ncbi.nlm.nih.gov/pubmed/24152295" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="kt195"><img alt="KT195" class="wide" src="img/structures/KT195.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>KT195</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/53364533" target="_blank">53364533</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1402612-58-1</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(4-(4'-methoxy-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)(2-phenylpiperidin-1-yl)methanone</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>438.53</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.sigmaaldrich.com/catalog/product/sigma/sml1308" target="_blank">Sigma</a> <a href="https://www.caymanchem.com/product/14818" target="_blank">Cayman</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>KT195 is a potent covalent inhibitor of ABHD6, initially developed alongside DAGL&beta; inhibitors to control for their off-targets. KT195 (IC50 = 10 nM) blocked fluorophosphonate-rhodamine labeling of ABHD6 in the membrane fraction
                                                        of mouse brain homogenates and showed no appreciable cross-reativity with DAGL&beta; (10 &micro;M). KT195 inhibited ABHD6 in Neuro2a cells (IC50 ~ 1 nM; ~100% at 10 nM) and showed negligible activity against other serine hydrolases
                                                        (25 nM). Consistent with the notion that ABHD6 acts as a 2-AG hydrolase, KT195 (25 nM, 4 h) caused an elevation of cellular 2-AG levels in Neuro2A cells but had no effect on diacylglycerols or arachidonic acid. In mice, KT195 (5 mg·kg<sup>-1</sup>,
                                                        i.p., 4 h) completely inhibited ABHD6 in peritoneal macrophages with minimal cross-reactivity (CES3, CES2G, and PLA2G15).</p>
                                                    <ol class="refs">
                                                        <li class="cite">Hsu, K. L., Tsuboi, K., Adibekian, A., Pugh, H., Masuda, K., and Cravatt, B. F. (2012) DAGLbeta inhibition perturbs a lipid network involved in macrophage inflammatory responses, Nat. Chem. Biol. 8, 999-1007.
                                                            <a href="https://doi.org/10.1038/nchembio.1105" target="_blank">DOI</a>
                                                            <a href="https://www.ncbi.nlm.nih.gov/pubmed/23103940" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="wwl70"><img alt="WWL70" class="wide" src="img/structures/WWL70.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>WWL70</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/17759121" target="_blank">17759121</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>947669-91-2</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>4'-carbamoyl-[1,1'-biphenyl]-4-yl methyl(3-(pyridin-4-yl)benzyl)carbamate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>437.50</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.sigmaaldrich.com/catalog/product/sigma/sml1641" target="_blank">Sigma</a> <a href="https://www.caymanchem.com/product/10011213" target="_blank">Cayman</a> <a href="https://www.trc-canada.com/product-detail/?W700503"
                                                        target="_blank">TRC</a> <a href="https://www.scbt.com/scbt/product/wwl70-947669-91-2" target="_blank">SCBT</a> <a href="http://www.arkpharminc.com/product/detail/AK213222.html" target="_blank">Ark Pharm</a> <a href="http://online.aurorafinechemicals.com/info?ID=A18.033.969"
                                                        target="_blank">Aurora</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>WWL70 is a first-generation potent and highly selective covalent inhibitor of the enzyme ABHD6, which hydrolyzes the endocannabinoid 2-arachidonoyl glycerol. WWL70 blocked fluorophosphonate-rhodamine labeling of ABHD6 (IC50 = 70 nM)
                                                        in membrane lysates from transfected HEK293T cells. Even at substantially higher concentrations (10 &micro;M), WWL70 showed negligible cross-reactivity with other serine hydrolases in mouse brain membrane, with the exception of ABHD10
                                                        (~30% inhibition).</p>
                                                    <p>Prentki <em>et al.</em> have also used WWL70 in DIO mice (10 mg·kg<sup>-1</sup>, i.p., daily for 8 weeks), which resulted in elevated markers of browning-related genes (e.g. Uncoupling protein 1) in visceral adipose tissue, akin to
                                                        the effects observed in ABHD6 antisense oligonucleotide(ASO)-treated mice.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Li, W., Blankman, J. L., and Cravatt, B. F. (2007) A Functional Proteomic Strategy to Discover Inhibitors for Uncharacterized Hydrolases, J. Am. Chem. Soc. 129, 9594-9595.
                                                            <a target="_blank" href="https://doi.org/10.1021/ja073650c">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/17629278">PubMed</a>
                                                        </li>
                                                        <li class="cite">Zhao, S., Mugabo, Y., Ballentine, G., Attane, C., Iglesias, J., Poursharifi, P., Zhang, D., Nguyen, T. A., Erb, H., Prentki, R., Peyot, M. L., Joly, E., Tobin, S., Fulton, S., Brown, J. M., Madiraju, S. R., and
                                                            Prentki, M. (2016) &alpha;/&beta;-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 Diabetes, Cell Rep 14, 2872-2888.
                                                            <a target="_blank" href="https://doi.org/j.celrep.2016.02.076">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/26997277">PubMed</a>
                                                        </li>

                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />


                            </div>
                        </div>
                    </div>

                    <!--abhd 11-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse4">ABHD11</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse4">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="ml226"><img alt="ML226" class="square" src="img/structures/ML226.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>ML226</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/71304779" target="_blank">71304779</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2055172-43-3</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(2-ethylpiperidin-1-yl)(4-(hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl)methanone</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>390.49</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://aobious.com/aobious/enzyme-inhibitors/2278-ml226.html" target="_blank">AOBIOUS</a>
                                                    <a href="http://glixxlabs.com/chemical-products/molecular-library_p4/GLXC-02169" target="_blank">Glixx Labs</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>ML226 is a potent inhibitor of ABHD11, with an IC50 of 15 nM and least 100-fold selectivity for ABHD11 over all other serine hydrolases in soluble proteome derived from mouse T cells (~20), as assessed by gel-based competitive ABPP
                                                        with fluorophosphonate-rhodamine. ML226 is also active in cells, where it completely and selectively inhibits ABHD11 at sub-nanomolar concentrations.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Adibekian A, Hsu KL, Speers AE, Brown SJ, Spicer T, Fernandez-Vega V, Ferguson J, Cravatt BF, Hodder P, and Rosen H. Optimization and characterization of a triazole urea inhibitor for alpha/beta hydrolase
                                                            domain-containing protein 11 (ABHD11): anti-probe for LYPLA1/LYPLA2 dual inhibitor ML211. 2011 Mar 31 [Updated 2013 Mar 7]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for
                                                            Biotechnology Information (US); 2010-.
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/23658953">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                            </div>
                        </div>
                    </div>

                    <!--ABHD12-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse11">ABHD12</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse11">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="do264"><img alt="DO264" class="wide" src="img/structures/DO264.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>DO264</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/134813646" target="_blank">134813646</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2301866-59-9</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>1-(1-(3-chloro-4-(2-chloro-4-(trifluoromethoxy)phenoxy)pyridin-2-yl)piperidin-4-yl)-3-(pyridin-3-yl)thiourea</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>558.40</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.medchemexpress.com/DO-264.html" target="_blank">MedChemExpress</a>
                                                    <a href="http://www.dcchemicals.com/product_show-DO264.html" target="_blank">DC Chemicals</a>
                                                    <a href="http://www.probechem.com/products_DO264.aspx" target="_blank">ProbeChem</a>
                                                    <a href="http://www.glixxlabs.com/chemical-products/bioactive-screen-leads-p6/GLXC-20680" target="_blank">Glixx Labs Inc</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>DO264 is a potent, selective, in vivo active inhibitor of ABHD12 that was developed from a high-throughput screening lead. ABHD12 is an &alpha;/&beta; hydrolase that cleaves lyso-phosphatidylserine (lyso-PS) lipids, which are signaling molecules that modulate immune function in vivo. DO264 potently inhibited ABHD12 in mouse brain membrane proteomes (IC50 value = 6.4 nM) as determined by gel ABPP experiments against FP-Rh (1 &micro;M, 45 min, 37 °C). DO264 also inhibited lyso-PS hydrolytic activity in lysates from mouse brain membrane (IC50 value = 2.8 nM) and human THP-1 cells (IC50 value = 6.4 nM). DO264 (0.001–1 &micro;M, 4 h) dose-dependently increased lyso-PS and 20:4 PS levels in THP-1 cells (2 - 5x), and in primary human macrophages (1.3 - 2x increase, 1 &micro;M, 24 h).</p>
                                                    <p>C57BL/6 mice treated with DO264 (i.p. / p.o.) showed dose-dependent elevations in brain lyso-PS lipids, with 30 mg·kg<sup>-1</sup> being sufficient to produce the largest increases observed (2 - 5x). DO264 treated mice (30 mg·kg<sup>-1</sup> i.p. daily) displayed heightened immune responses in the LCMV clone 13 (Cl13) model of immune challenge: treated animals had decreased overall survival rates (~-40% after 20 days) and lung fluid (bronchoalveolar lavage) from these mice showed increased total protein (~10x) and pro-inflammatory cytokines (~2-3x) relative to control-treated animals.</p>
                                                    <p>Together, DO264, its inactive control analog <a class="js-scroll-trigger" href="#do271">(S)-DO271</a>, and ABHD12<sup>–/–</sup> mice are powerful tools for understanding the biological function of ABHD12 and its pharmacological potential.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Ogasawara, D, Ichu, T.-A., Vartabedian, V. F., Benthuysen, J., Jing, H., Reed, A., Ulanovskaya, O. A., Hulce, J. J., Roberts, A., Brown, S., Rosen, H, Teijaro, J. R., and Cravatt, B. F. (2018) Selective blockade of the lyso-​PS lipase ABHD12 stimulates immune responses in vivo, Nat. Chem. Biol. 14, 1099-1108.
                                                            <a target="_blank" href="https://doi.org/10.1038/s41589-018-0155-8">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/30420694">PubMed</a>
                                                        </li>
                                                        <li class="cite">Ogasawara, D., Ichu, T.-A., Jing, H, Hulce, J. J., Reed, A., Ulanovskaya, O. A., and Cravatt, B. F. (2019) Discovery and Optimization of Selective and in Vivo Active Inhibitors of the Lysophosphatidylserine Lipase &alpha;​/&beta;-​Hydrolase Domain-​Containing 12 (ABHD12), J. Med. Chem. 62, 1643-1656.
                                                            <a target="_blank" href="https://doi.org/10.1021/acs.jmedchem.8b01958">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/30720278">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="do271"><img alt="DO271" class="wide" src="img/structures/DO271.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>(S)-DO271</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for <a href="#do264" class="js-scroll-trigger">DO264</a></td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/134813650" target="_blank">134813650</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2301865-01-8</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>1-[(3S)-1-[3-chloro-4-[2-chloro-4-(trifluoromethoxy)phenoxy]pyridin-2-yl]piperidin-3-yl]-3-pyridin-3-ylthiourea</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>558.40</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="./material_request_form.html?item=(S)-DO271" target="_blank" class="btn btn-default">Request</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>(S)-DO271 is a structurally-similar, ABHD12-inactive analog of <a href="#do264" class="js-scroll-trigger">DO264</a> developed to control for potential off-target effects, particularly those that might occur due to the thiourea motif.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Ogasawara, D, Ichu, T.-A., Vartabedian, V. F., Benthuysen, J., Jing, H., Reed, A., Ulanovskaya, O. A., Hulce, J. J., Roberts, A., Brown, S., Rosen, H, Teijaro, J. R., and Cravatt, B. F. (2018) Selective blockade of the lyso-​PS lipase ABHD12 stimulates immune responses in vivo, Nat. Chem. Biol. 14, 1099-1108.
                                                            <a target="_blank" href="https://doi.org/10.1038/s41589-018-0155-8">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/30420694">PubMed</a>
                                                        </li>
                                                        <li class="cite">Ogasawara, D., Ichu, T.-A., Jing, H, Hulce, J. J., Reed, A., Ulanovskaya, O. A., and Cravatt, B. F. (2019) Discovery and Optimization of Selective and in Vivo Active Inhibitors of the Lysophosphatidylserine Lipase &alpha;​/&beta;-​Hydrolase Domain-​Containing 12 (ABHD12), J. Med. Chem. 62, 1643-1656.
                                                            <a target="_blank" href="https://doi.org/10.1021/acs.jmedchem.8b01958">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/30720278">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                            </div>
                        </div>
                    </div>

                    <!--aig adtrp-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse5">AIG1 / ADTRP</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse5">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="jjh260"><img alt="JJH260" class="wide" src="img/structures/JJH260.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>JJH260</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/71710928" target="_blank">71710928</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1831135-30-8</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>7-(4-(dimethylamino)benzoyl)-1,3-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl 4-(4-chlorophenethyl)piperidine-1-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>567.22</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.caymanchem.com/product/19384" target="_blank">Cayman</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>JJH260 is a covalent inhibitor of AIG1 and ADTRP, two closely-related, atypical integral membrane hydrolases that can hydrolyze fatty acid esters of hydroxy fatty acids (FAHFAs). JJH260 blocked flurophosphonate rhodamine
                                                        probe-labeling of AIG1 (IC50 = 0.5 &micro;M) and ADTRP (IC50 = 8.5 &micro;M) overexpressed individually in HEK293T cells. JJH260 had limited cross-reactivity with other serine hydrolases, which could be controlled for by using ABC34
                                                        (with the exception of LYPLA1/2). JJH260 also inhibited FAHFA hydrolysis by AIG1 in transfected HEK293T cells (IC50 = 0.6 &micro;M) and at higher concentrations (5 &micro;M), strongly inhibits (>80%) the FAHFA hydrolase activity in
                                                        AIG1-transfected HEK293T cells, LNCaP cells, and membrane fractions from human T cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parsons, W. H., Kolar, M. J., Kamat, S. S., Cognetta, A. B., 3rd, Hulce, J. J., Saez, E., Kahn, B. B., Saghatelian, A., and Cravatt, B. F. (2016) AIG1 and ADTRP are atypical integral membrane hydrolases that degrade
                                                            bioactive FAHFAs, Nat. Chem. Biol. 12, 367-372.
                                                            <a target="_blank" href="https://doi.org/10.1038/nchembio.2051">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27018888">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><img alt="ABC34" class="wide" src="img/structures/ABC34.png"></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>ABC34</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for <a href="#jjh260" class="js-scroll-trigger">JJH260</a></td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/118525588" target="_blank">118525588</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1831135-56-8</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>1,3-dioxo-7-(4-phenoxybenzyl)hexahydroimidazo[1,5-a]pyrazin-2(3H)-yl 4-(4-methoxyphenyl)piperazine-1-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>571.63</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.caymanchem.com/product/19385" target="_blank">Cayman</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>ABC34 is a control compound that is structurally similar to <a href="#jjh260" class="js-scroll-trigger">JJH260</a>, most notably, containing the same reactive N-hydroxyhydantoin carbamate reactive group. Unlike <a href="#jjh260"
                                                            class="js-scroll-trigger">JJH260</a>, ABC34 (5 &micro;M) did not react with AIG/ADTRP and can be used to control for the off-targets of JJH260 (e.g. ABHD6, PPT1, CES2).</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parsons, W. H., Kolar, M. J., Kamat, S. S., Cognetta, A. B., 3rd, Hulce, J. J., Saez, E., Kahn, B. B., Saghatelian, A., and Cravatt, B. F. (2016) AIG1 and ADTRP are atypical integral membrane hydrolases that degrade
                                                            bioactive FAHFAs, Nat. Chem. Biol. 12, 367-372.
                                                            <a target="_blank" href="https://doi.org/10.1038/nchembio.2051">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27018888">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="kc01_aig"><img alt="KC01" class="wide" src="img/structures/KC01.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>KC01</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/86289046" target="_blank">86289046</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1646795-59-6</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(Z)-6-(2-oxo-4-tridecyloxetan-3-ylidene)hexanamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>365.56</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.caymanchem.com/product/17364" target="_blank">Cayman</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>KC01 is a covalent inhibitor of AIG1 and ADTRP, two closely-related, atypical integral membrane hydrolases that can hydrolyze fatty acid esters of hydroxy fatty acids (FAHFAs). KC01 has a distinct reactive group (beta-lactone) from
                                                        the <i>N</i>-hydroxyhydantoin carbamate <a href="#jjh260" class="js-scroll-trigger">JJH260</a>. KC01 blocked fluorophosphonate-rhodamine labeling of AIG1 (IC50 = 0.2 &micro;M) and ADTRP (IC50 = 1.3 &micro;M) overexpressed individually
                                                        in HEK293T cells. KC01 is less selective than JJH260 (cross-reacts with ABHD16A, PAFAH2, ABHD3, etc.), which can be largely controlled for by using ABC34. KC01 (5 &micro;M), strongly inhibits (>80%) the FAHFA hydrolase activity in
                                                        AIG1-transfected HEK293T cells, LNCaP cells, and membrane fractions from human T cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parsons, W. H., Kolar, M. J., Kamat, S. S., Cognetta, A. B., 3rd, Hulce, J. J., Saez, E., Kahn, B. B., Saghatelian, A., and Cravatt, B. F. (2016) AIG1 and ADTRP are atypical integral membrane hydrolases that degrade
                                                            bioactive FAHFAs, Nat. Chem. Biol. 12, 367-372.
                                                            <a target="_blank" href="https://doi.org/10.1038/nchembio.2051">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27018888">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />


                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="whp01"><img alt="WHP01" class="square" src="img/structures/WHP01.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>WHP01</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Activity-based Probe</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/86289026" target="_blank">86289026</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1646795-61-0</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(Z)-3',6'-bis(dimethylamino)-3-oxo-N-(5-(5-(2-oxo-4-tridecyloxetan-3-ylidene)pentanamido)pentyl)-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>849.13</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=WHP01" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>WHP01 is a sensitive, fluorescent activity-based probe for AIG1 and ADTRP, which can be used to detect endogenous AIG1 and ADTRP activity in LNCap cells (2 &micro;M, 30 min, 37 &deg;C).</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parsons, W. H., Kolar, M. J., Kamat, S. S., Cognetta, A. B., 3rd, Hulce, J. J., Saez, E., Kahn, B. B., Saghatelian, A., and Cravatt, B. F. (2016) AIG1 and ADTRP are atypical integral membrane hydrolases that degrade
                                                            bioactive FAHFAs, Nat. Chem. Biol. 12, 367-372. <a target="_blank" href="https://doi.org/10.1038/nchembio.2051">DOI</a> <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27018888">PubMed</a></li>
                                                        <li class="cite">Kamat, S. S., Camara, K., Parsons, W. H., Chen, D. H., Dix, M. M., Bird, T. D., Howell, A. R., and Cravatt, B. F. (2015) Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay, Nat Chem
                                                            Biol 11, 164-171. <a target="_blank" href="https://doi.org/10.1038/nchembio.1721">DOI</a> <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/25580854">PubMed</a></li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                            </div>
                        </div>
                    </div>

                    <!--notum-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse10">NOTUM</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse10">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="abc99"><img alt="abc99" class="wide" src="img/structures/ABC99.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>ABC99</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/134817170" target="_blank">134817170</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>7-(4-chlorobenzyl)-1,3-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>456.88</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.caymanchem.com/product/25858" target="_blank">Cayman</a>
                                                    <a href="https://www.aablocks.com/goods/Goods/detail?id=AA01EQAI" target="_blank">AA Blocks</a>
                                                    <a href="http://www.dcchemicals.com/product_show-DC10929.html" target="_blank">DC Chemicals</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>ABC99 is a potent and selective inhibitor of NOTUM, a secreted serine hydrolase that modulates Wnt signaling. Wnt proteins are post-translationally modified (palmitoleoylation, C18:1) on a conserved serine residue by the acyltransferase porcupine (PORCN) and deacylated by NOTUM. These events control Wnt pathway output which in turn affects biological processes such as tissue regeneration and cell proliferation.</p>
                                                    <p>ABC99 strongly inhibited NOTUM in SW620 cell conditioned media (IC50 value = 13 nM, 2 h, 37 °C) as determined by competitive ABPP (FP-Rh) and showed no detectable activity across 64 additional serine hydrolases quantified by MS-ABPP in SW620 cells. ABC99 also preserved Wnt signaling (IC50 value = 89 nM) in a cell-based luciferase reporter assay of Wnt activation (HEK293T-STF cells), in which conditioned media (CM) from Wnt3A-producing L-cells was mixed with CM from NOTUM-producing SW620 cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Suciu, R. M., Cognetta, A. B., 3rd, Potter Z. E., and Cravatt, B. F. (2018) Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling ACS Med. Chem. Lett. 9, 563-568.
                                                            <a target="_blank" href="https://doi.org/10.1021/acsmedchemlett.8b00191">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/29937983">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />

                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="abc99yne"><img alt="abc99yne" class="wide" src="img/structures/ABC99yne.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>ABC99yne</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Probe</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/" target="_blank"></a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>7-(4-chlorobenzyl)-1,3-dioxohexahydroimidazo[1,5-a]pyrazin-2(3H)-yl 4-(prop-2-yn-1-yl)-3,4-dihydroquinoxaline-1(2H)-carboxylate</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>493.95</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">

                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>ABC99yne is a sensitive, highly-selective "click"-able probe of NOTUM, based on <a class="js-scroll-trigger" href="#abc99">ABC99</a>. ABC99yne blocked NOTUM labeling by FP-Rh (IC50 value < 1 &microM;, conditioned media from SW620 cells) and strongly labeled a single protein band at ~52 kDa, when "clicked" with rhodamine-azide; no other cross-reactive proteins were observed in conditioned media or cell lysates from SW620 cells (at 0.1 μM).</p>

                                                    <ol class="refs">
                                                        <li class="cite">Suciu, R. M., Cognetta, A. B., 3rd, Potter Z. E., and Cravatt, B. F. (2018) Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling ACS Med. Chem. Lett. 9, 563-568.
                                                            <a target="_blank" href="https://doi.org/10.1021/acsmedchemlett.8b00191">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/29937983">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                            </div>
                        </div>
                    </div>

                    <!--PAFAH-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse9">PAFAH1b2/3</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse9">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="p11"><img alt="P11" class="square" src="img/structures/P11.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>P11</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/16656440" target="_blank">16656440</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>942285-55-4</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>cis-2-(4-(tert-butyl)phenyl)-6-(p-tolyl)-1-tosyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>503.66</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="https://www.caymanchem.com/product/17507" target="_blank">Cayman</a>
                                                    <a href="https://aksci.com/item_detail.php?cat=SYN5680" target="_blank">AK Scientific</a>
                                                    <a href="https://aobious.com/aobious/hydroxylases/788-p11.html" target="_blank">AOBIOUS</a>
                                                    <a href="http://glixxlabs.com/chemical-products/bioactive-screen-leads-p6/GLXC-05835" target="_blank">Glixx Labs</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>P11 is a non-covalent platelet activation factor acetylhydrolase (PAFAH) 1b2/1b3 inhibitor found through a fluorescence polarization-activity-based protein profiling screen of the National Institute of Health 300,000+ compound
                                                        library. P11 inhibited PAFAH1b2 and PAFAH1b3 (IC50 values of ∼40 and 900 nM respectively) in a PAF substrate assay and showed no cross-reactivity with other brain serine hydrolases, including other PAFAHs such as PLA2G7 and PAFAH2.
                                                        P11 (10 &micro;M) also impaired the survival of PC3 and Neuro2a cancer cells by approximately 50%.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Chang, J. W., Zuhl, A. M., Speers, A. E., Niessen, S., Brown, S. J., Mulvihill, M. M., Fan, Y. C., Spicer, T. P., Southern, M., Scampavia, L., Fernandez-Vega, V., Dix, M. M., Cameron, M. D., Hodder, P. S., Rosen, H.,
                                                            Nomura, D. K., Kwon, O., Hsu, K. L., and Cravatt, B. F. (2015) Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival, ACS Chem Biol 10, 925-932.
                                                            <a target="_blank" href="https://doi.org/10.1021/cb500893q">DOI</a>
                                                            <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/25602368">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                            </div>
                        </div>
                    </div>

                    <!--PTGR2-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse6">PTGR2</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse6">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="knj57"><img alt="KNJ57" class="square" src="img/structures/KNJ057.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>KNJ57</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/912698" target="_blank">912698</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>349093-44-3</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>1-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylethan-1-one</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>CGP201722</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>310.40</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="http://online.aurorafinechemicals.com/info?ID=K01.920.433" target="_blank">Aurora</a> <a href="https://labnetwork.com/frontend-app/p/#%21/moleculedetails/LN00972886" target="_blank">LabNetwork</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>KNJ57 is an optimized inhibitor of the prostaglandin-metabolizing enzyme PTGR2. KNJ57 (0.5 &micro;M, ~80%; 5 &micro;M, 100% inhibition) selectively blocked <a href="#cgp201708" class="js-scroll-trigger">CGP201708</a> (20 &micro;M)
                                                        labeling of endogenous PTGR2 in HEK293T cells, without engaging ZADH2, another reductase enzyme that has high sequence similarity to PTGR2. KNJ57 (IC50 = 0.55 &micro;M) inhibited recombinant PTGR2, blocking the production of 13,
                                                        14-dihydro-15-keto prostaglandin E2 from 15-keto prostaglandin E2. KNJ57 (0.6 – 5 &micro;M) increased 15-keto-PGE2-dependent PPARγ transcriptional activity in PTGR2-transfected HEK293T cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29.
                                                            <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a>
                                                            <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><img alt="KNJ051" class="square" src="img/structures/KNJ051.png"></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>KNJ51</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for <a href="#knj57" class="js-scroll-trigger">KNJ57</a></td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274142" target="_blank">132274142</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2094991-61-2</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>1-(benzylsulfonyl)-4-(2-methoxyphenyl)piperidine</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>CGP201723</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>345.46</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=KNJ51" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>KNJ51 is a structurally-related control compound for <a href="#knj57" class="js-scroll-trigger">KNJ57</a> that does not inhibit PTGR2. KNJ51 (100 &micro;M) did not inhibit recombinant PTGR2 and had no effect on
                                                        15-keto-PGE2-dependent PPARγ transcriptional activity in PTGR2-transfected HEK293T cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201708"><img alt="CGP201708" class="wide" src="img/structures/CGP201708.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201708</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Photoaffinity probe</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274143" target="_blank">132274143</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2089059-93-6</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)-1-(4-phenylpiperidin-1-yl)propan-1-one</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>310.40</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=CGP201708" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201708 is a photoreactive clickable fragment probe that bears a phenylpiperidine group. CGP201708 (20 or 200 &micro;M) was found to enrich hundreds of proteins, including PTGR2, from HEK293T cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                            </div>
                        </div>
                    </div>

                    <!--slc25a20-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse7">SLC25A20</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse7">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201721"><img alt="CGP201721" class="tall" src="img/structures/CGP201721.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201721</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Inhibitor</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/47089244" target="_blank">47089244</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>1241469-17-9</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>7-methyl-4-((2-((methyl(phenyl)amino)methyl)pyrrolidin-1-yl)methyl)-2H-chromen-2-one</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>362.47</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="http://online.aurorafinechemicals.com/info?ID=A32.981.688" target="_blank">Aurora</a> <a href="https://www.enaminestore.com/catalog/Z968724936" target="_blank">Enamine</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201721 was identified as a relatively selective competitor of the mitochondrial carnitine/acylcarnitine transporter SLC25A20 in competitive chemoproteomic experiments with photoaffinity probe <a href="#cgp201703" class="js-scroll-trigger">CGP201703</a>
                                                        in HEK293T cells. CGP201721 (20–100 &micro;M) increased long-chain (C16, C18, C18:1) acylcarnitines (~5-20 fold) and decreased exogenous fatty acid oxidation (~60-90% inhibition) in HSC-5 cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><img alt="CGP201724" class="square" src="img/structures/CGP201724.png"></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201724</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for <a href="#cgp201721" class="js-scroll-trigger">CGP201721</a></td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/24280187" target="_blank">24280187</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>929490-21-1</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>N-(2-(6-chloro-7-methyl-2-oxo-2H-chromen-4-yl)benzofuran-3-yl)cyclopropanecarboxamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>362.47</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers">
                                                    <a href="http://online.aurorafinechemicals.com/info?ID=A32.669.109" target="_blank">Aurora</a> <a href="https://labnetwork.com/frontend-app/p/#%21/moleculedetails/LN01060488" target="_blank">LabNetwork</a> <a href="https://shop.lifechemicals.com/2/F2656-0250"
                                                        target="_blank">Life Chemicals</a>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201724 is a structurally-related inactive analog of <a href="#cgp201721" class="js-scroll-trigger">CGP201721</a> that does not engage SLC25A20. CGP201724 (100 &micro;M) had no effect on long-chain acylcarnitines or fatty acid
                                                        oxidation in HSC-5 cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201703"><img alt="CGP201703" class="wide" src="img/structures/CGP201703.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201703</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Photoaffinity probe</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274144" target="_blank">132274144</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2089043-46-7</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)-N-(2-oxo-2H-chromen-6-yl)propanamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>309.33</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=CGP201703" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201703 is a photoreactive clickable fragment probe that bears a chromenone group. CGP201703 (20 or 200 &micro;M) was found to enrich hundreds of proteins, including SLC25A20, from HEK293T cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                            </div>
                        </div>
                    </div>

                    <!--pgrmc2-->
                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse8">PGRMC2</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse8">
                            <div class="panel-body">
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201725"><img alt="CGP201725" class="wide" src="img/structures/CGP201725.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201725</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Photoaffinity probe / Gain-of-function ligand</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274145" target="_blank">132274145</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2089047-53-8</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(S)-2-(3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanamido)-4-methyl-N-(naphthalen-2-yl)pentanamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>404.51</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=CGP201725" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201725 was discovered from a screen for compounds that promoted the differentiation of 3T3-L1 mouse preadipocytes to adipocytes by mechanisms distinct from that of the PPARγ agonist rosiglitazone. CGP201725 (10 &micro;M) induced
                                                        key adipogenic markers (e.g., <em>Pparg</em>, <em>Fabp4</em>, <em>Cd36</em>) in differentiating 3T3-L1s, human mesenchymal stem cells (hMSCs), 10T1/2 cells, and primary brown preadipocytes.</p>
                                                    <p>Comparative chemoproteomic studies in 3T3-L1s with inactive compound <a href="#cgp201726" class="js-scroll-trigger">CGP201726</a> revealed PGRMC2 as the target of CGP201725, and site-of-labeling studies indicated that it binds in
                                                        the protein's cytochrome b5 heme-binding domain. Hemin (IC50 = 40 &micro;M) and protoporphyrin IX (IC50 = 0.13 &micro;M) competed CGP201725 (10 &micro;M) labeling of overexpressed PGRMC2 in HEK293T cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201727"><img alt="CGP201727" class="square" src="img/structures/CGP201727.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201727</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Gain-of-function ligand</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274146" target="_blank">132274146</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2094991-62-3</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(S)-2-butyramido-4-methyl-N-(naphthalen-2-yl)pentanamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>326.44</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=CGP201727" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201727 is an active analog of <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> which promoted adipogenesis in 3T3-L1s and hMSCs (human mesenchymal stem cells). CGP201727 lacks the photoreactive and clickable groups
                                                        present in <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> and dose-dependently competed <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> (10 &micro;M) labeling of overexpressed PGRMC2 in HEK293T cells.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201726"><img alt="CGP201726" class="wide" src="img/structures/CGP201726.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201726</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Photoaffinity probe; control for <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a>/<a href="#cgp201727" class="js-scroll-trigger">CGP201727</a></td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274147" target="_blank">132274147</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2089058-18-2</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(S)-3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)-N-(1-((4-methoxynaphthalen-2-yl)amino)-1-oxopropan-2-yl)propanamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>329.46</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=CGP201726" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201726 is an inactive compound structurally similar to <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> which did not promote adipogenesis or engage PGRMC2 (at 10 &micro;M). Because it still has photoreactive and
                                                        clickable groups, it was used as a control probe in chemoproteomic studies to determine that PGRMC2 is the relevant target of <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a>.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201728"><img alt="CGP201728" class="square" src="img/structures/CGP201728.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201728</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for CGP201725/CGP201727</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274148" target="_blank">132274148</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2094991-63-4</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(S)-N-(1-((4-methoxynaphthalen-2-yl)amino)-1-oxopropan-2-yl)butyramide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>314.39</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=CGP201728" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201728 is an inactive compound structurally similar to <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> which did not promote adipogenesis or engage PGRMC2 (at 10 &micro;M). It does not bear photoreactive or clickable
                                                        groups.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201729"><img alt="CGP201729" class="square" src="img/structures/CGP201729.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201729</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for CGP201725/CGP201727</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274149" target="_blank">132274149</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2089060-72-8</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(S)-2-butyramido-4-methyl-N-((S)-1,2,3,4-tetrahydronaphthalen-1-yl)pentanamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>330.47</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=CGP201729" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201729 is an inactive compound structurally similar to <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> which did not promote adipogenesis or engage PGRMC2 (at 10 &micro;M). It does not bear photoreactive or clickable
                                                        groups.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                                <hr class="cmpd_spacer" />
                                <div class="cmpd">
                                    <table class="cmpd_data">
                                        <thead>
                                            <tr>
                                                <td colspan="2"><a id="cgp201730"><img alt="CGP201730" class="square" src="img/structures/CGP201730.png"></a></td>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <th>Name:</th>
                                                <td>CGP201730</td>
                                            </tr>
                                            <tr>
                                                <th>Activity:</th>
                                                <td>Control compound for CGP201725/CGP201727</td>
                                            </tr>
                                            <tr>
                                                <th>PubChem CID:</th>
                                                <td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/132274150" target="_blank">132274150</a></td>
                                            </tr>
                                            <tr>
                                                <th>CAS #:</th>
                                                <td>2089060-74-0</td>
                                            </tr>
                                            <tr>
                                                <th>Sys. name:</th>
                                                <td>(S)-N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-2-butyramido-4-methylpentanamide</td>
                                            </tr>
                                            <tr>
                                                <th>Synonyms:</th>
                                                <td>–</td>
                                            </tr>
                                            <tr>
                                                <th>Mol. wt.:</th>
                                                <td>348.44</td>
                                            </tr>
                                            <tr>
                                                <th>Suppliers:</th>
                                                <td class="suppliers"><a href="./material_request_form.html?item=CGP201730" target="_blank" class="btn btn-default">Request</a></td>
                                            </tr>
                                            <tr>
                                                <td class="cmpd_desc" colspan="2">
                                                    <p>CGP201730 is an inactive compound structurally similar to <a href="#cgp201725" class="js-scroll-trigger">CGP201725</a> which did not promote adipogenesis or engage PGRMC2 (at 10 &micro;M). It does not bear photoreactive or clickable
                                                        groups.</p>
                                                    <ol class="refs">
                                                        <li class="cite">Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., and Cravatt, B. F. (2017) Ligand and Target
                                                            Discovery by Fragment-Based Screening in Human Cells, Cell 168, 527-541.e29. <a href="https://doi.org/10.1016/j.cell.2016.12.029" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/28111073" target="_blank">PubMed</a>
                                                        </li>
                                                    </ol>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>

                            </div>
                        </div>
                    </div>

                </div>
            </div>
        </div>
    </div>
</section>

<section id="models">
    <div class="container">
        <div class="row">
            <div class="col-lg-12 text-center">
                <h2 class="section-heading">Genetic Models</h2>
                <hr>

                <div class="panel-group" id="accordion_ko">

                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse_ko_1">DDHD2</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse_ko_1">
                            <div class="panel-body">
                                <div class="knockout">
                                    <p><em>Whole-body or conditional knockout:</em> Whole-body</p>
                                    <p><em>Viability:</em> DDHD2<sup>-/-</sup> mice were viable; born at expected Mendelian frequency</p>
                                    <p>DDHD2<sup>-/-</sup> mice were fertile and largely exhibited normal cage behavior and general ambulation. However, aged DDHD2<sup>-/-</sup> mice (6 months) had locomotor defects, including shorter stride lengths, reductions in rearing
                                        behavior, and poorer motor coordination when compared to wildtype mice. DDHD2<sup>-/-</sup> mice did not show differences in vision or willingness to explore new environments (Y-maze test), but had impaired spatial learning and memory
                                        (Barnes maze), including long-term spatial memory (re-evaluation after 2 weeks).</p>
                                    <p>Adult (2–4 month-old) DDHD2<sup>-/-</sup> mice showed accumulation of several triacylglycerol species (TAG; ~3–5 fold) in their brains, whereas other major lipid classes (e.g., phospholipids, lysophospholipids, free fatty acids,
                                        monoglycerols, and diacylglcerols) were unchanged. Older (10 month) mice showed similar accumulation. DDHD2<sup>+/-</sup> mice did not accumulate TAGs in their brains. TAG accumulation in DDHD2<sup>-/-</sup> was age dependent: 3-week-old
                                        mice did not show accumulation of many TAGs compared to 2-month-old mice.</p>
                                    <p>DDHD2<sup>-/-</sup> mice had an increased number, area, and diameter of lipid droplets (LD) in their brains. LD accumulation appeared to be present primarily in neurons (and not in glia) and LD were often surrounded by organelles,
                                        including mitochondria.</p>

                                    <ol class="refs">
                                        <li class="cite">Inloes, J. M., Hsu, K.-L., Dix, M. M., Viader, A., Masuda, K., Takei, T., Wood, M. R., and Cravatt, B. F. (2014) The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase, Proc. Natl.
                                            Acad. Sci. U.S.A. 111, 14924-14929. <a href="https://doi.org/10.1073/pnas.1413706111" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/25267624" target="_blank">PubMed</a>
                                        </li>
                                    </ol>

                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse_ko_2">ABHD12</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse_ko_2">
                            <div class="panel-body">
                                <div class="knockout">
                                    <p><em>Whole-body or conditional knockout:</em> Whole-body</p>
                                    <p><em>Viability:</em> ABHD12<sup>-/-</sup> mice were viable; born at expected Mendelian frequency</p>
                                    <p>ABHD12<sup>-/-</sup> mice were fertile and generally indistinguishable from wildtype or heterozygous littermates. Young ABHD12<sup>-/-</sup> mice (5–6 months) were slightly hypermotile, but this behavior was not observed in later tests.
                                        They also showed a slight reduction in auditory startle reflex, which was not significant; however, older (11-12 months) mice had a significantly blunted startle response. Further studies revealed that this was likely due to reduced
                                        auditory conductance in ABHD12<sup>-/-</sup> mice. As ABHD12<sup>-/-</sup> mice aged further (17-18 months), they developed additional defects in motor coordination and showed muscle weakness, effects that were not observed in younger
                                        mice. ABHD12<sup>-/-</sup> mice were found to have normal vision and also exhibited heightened neuroinflammation.</p>

                                    <p>Lipidomic analysis of ABHD12<sup>-/-</sup> mice showed massive elevations (~6 to 40 fold) of very long chain lysophosphatidylserine (VLC-lysoPS) species (22:1, 22:0, and 24:0). More modest alterations were also found in other brain
                                        lipids, including some phosphatidylserines (PS), phosphatidylglycerols (PG), and lysophosphatidylinositols (LPI). In contrast, ABHD12 disruption did not affect levels of other (lyso)phospholipids or free fatty acids. Brains from ABHD12<sup>−/−</sup>
                                        mice showed a notably remodeled acyl chain distribution in PS lipids, with selective elevation of arachidonate-containing (20:4) species.</p>

                                    <ol class="refs">
                                        <li class="cite">Blankman, J. L., Long, J. Z., Trauger, S. A., Siuzdak, G., and Cravatt, B. F. (2013) ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC,
                                            Proc. Natl. Acad. Sci. U.S.A. 110, 1500-1505.<a href="https://doi.org/10.1073/pnas.1217121110" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/23297193" target="_blank">PubMed</a>
                                        </li>

                                        <li class="cite">Kamat, S. S., Camara, K., Parsons, W. H., Chen, D. H., Dix, M. M., Bird, T. D., Howell, A. R., and Cravatt, B. F. (2015) Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay, Nat Chem
                                            Biol 11, 164-171. <a target="_blank" href="https://doi.org/10.1038/nchembio.1721">DOI</a> <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/25580854">PubMed</a></li>
                                    </ol>

                                </div>

                            </div>
                        </div>
                    </div>


                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse_ko_3">ABHD6</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse_ko_3">
                            <div class="panel-body">
                                <div class="knockout">
                                    <p>We have generated ABHD6 whole-body null mice using a non-conditional allele. We have confirmed loss of ABHD6 activity but have not extensively characterized these mice. This unpublished strain is available to interested investigators.</p>

                                    <p>Using a conditional allele, Prentki <em>et al.</em> have reported the generation of whole-body and pancreas-specific ABHD6 null mice. Both of these strains show enhanced glucose-stimulated insulin secretion. In addition, total ABHD6
                                        null mice are more resistant to the metabolic deterioration driven by a high-fat diet.</p>

                                    <ol class="refs">
                                        <li class="cite">Zhao, S., Mugabo, Y., Ballentine, G., Attane, C., Iglesias, J., Poursharifi, P., Zhang, D., Nguyen, T. A., Erb, H., Prentki, R., Peyot, M. L., Joly, E., Tobin, S., Fulton, S., Brown, J. M., Madiraju, S. R., and Prentki,
                                            M. (2016) &alpha;/&beta;-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 Diabetes, Cell Rep 14, 2872-2888.<a href="https://doi.org/10.1016/j.celrep.2016.02.076" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/26997277"
                                                target="_blank">PubMed</a>
                                        </li>

                                        <li class="cite">Zhao, S., Mugabo, Y., Iglesias, J., Xie, L., Delghingaro-Augusto, V., Lussier, R., Peyot, M. L., Joly, E., Taib, B., Davis, M. A., Brown, J. M., Abousalham, A., Gaisano, H., Madiraju, S. R., and Prentki, M. (2014)
                                            &alpha;/&beta;-Hydrolase domain-6-accessible monoacylglycerol controls glucose-stimulated insulin secretion, Cell Metab 19, 993-1007.<a href="https://doi.org/10.1016/j.cmet.2014.04.003" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/24814481"
                                                target="_blank">PubMed</a>
                                        </li>


                                    </ol>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse_ko_4">PGRMC2</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse_ko_4">
                            <div class="panel-body">
                                <div class="knockout">
                                    <p>Tissue specific knockouts have been generated and are currently being characterized.</p>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse_ko_5">AIG/ADTRP</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse_ko_5">
                            <div class="panel-body">
                                <div class="knockout">
                                    <p>Whole-body knockouts have been generated using CRISPR technology and are currently being characterized.</p>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse_ko_6"><span class="non_caps">ThermoMouse</span></a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse_ko_6">
                            <div class="panel-body">
                                <div class="knockout">

                                    <p>ThermoMouse bacterial artificial chromosome (BAC) transgenic mice express luciferase under the control of the endogenous Uncoupling Protein 1 (Ucp1) promoter. Luciferase expression in these mice faithfully mimics Ucp1 expression and its
                                        response to physiologic stimuli, such as cold. ThermoMice can therefore be used to monitor Ucp1 expression in live animals in real time. They can be obtained from <a target="_blank" href="https://www.jax.org/strain/026690">JAX</a>.</p>

                                    <ol class="refs">
                                        <li class="cite">Galmozzi, A., Sonne, S. B., Keylin, S., Hasegawa, Y., Shinoda, K., Luijten, I. H. N., Chang, J. W., Sharp, L. Z., Cravatt, B. F., Saez, E., and Kajimura, S. (2014) ThermoMouse: an in vivo model to identify modulators of
                                            UCP1 expression in brown adipose tissue, Cell rep 9, 1584-1593.<a href="https://doi.org/10.1016/j.celrep.2014.10.066" target="_blank">DOI</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/25466254" target="_blank">PubMed</a>
                                        </li>
                                    </ol>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="panel panel-default">
                        <div class="panel-heading">
                            <h4 class="panel-title"><a aria-expanded="false" class="accordion-toggle collapsed" data-toggle="collapse" href="#collapse_ko_7">LYPLAL1</a></h4>
                        </div>
                        <div role="tabpanel" aria-expanded="false" class="panel-collapse collapse" id="collapse_ko_7">
                            <div class="panel-body">
                                <div class="knockout">
                                    <p>Whole-body and tissue specific knockouts have been generated and are currently being characterized.</p>
                                </div>
                            </div>
                        </div>
                    </div>


                </div>

            </div>
        </div>
    </div>
</section>

<section id="contact">
    <div class="container">
        <div class="row">
            <div class="col-lg-12 mx-auto text-center">
                <h2 class="section-heading">Project Team</h2>
                <hr class="primary">
            </div>
        </div>
        <div class="row">
            <div class="col-lg-2 ml-auto text-center">
                <p class="contact_name">Enrique Saez, Ph.D. <i class="fa fa-star" aria-hidden="true"></i></p>
                <p>Associate Professor</p>
                <p>Department of Molecular Medicine</p>
                <p>The Scripps Research Institute</p>
                <p class="email_address"><a href="mailto:esaez@scripps.edu">esaez@scripps.edu</a></p>
                <p>858-784-7305</p>
                <hr>
            </div>

            <div class="col-lg-2 ml-auto text-center">
                <p class="contact_name">Benjamin Cravatt, Ph.D.</p>
                <p>Professor</p>
                <p>Department of Chemistry</p>
                <p>Gilula Chair of Chemical Biology</p>
                <p>The Scripps Research Institute</p>
                <p class="email_address"><a href="mailto:cravatt@scripps.edu">cravatt@scripps.edu</a></p>
                <p>858-784-8633</p>
                <hr>
            </div>

            <div class="col-lg-2 ml-auto text-center">
                <p class="contact_name">Dale Boger, Ph.D.</p>
                <p>Richard and Alice Cramer Professor of Chemistry</p>
                <p>Department of Chemistry</p>
                <p>The Scripps Research Institute</p>
                <p class="email_address"><a href="mailto:boger@scripps.edu">boger@scripps.edu</a></p>
                <p>858-784-7522</p>
                <hr>
            </div>

            <div class="col-lg-2 ml-auto text-center">
                <p class="contact_name">Peter Tontonoz, M.D., Ph.D.</p>
                <p>Professor</p>
                <p>Pathology and Laboratory Medicine</p>
                <p>University of California, Los Angeles</p>
                <p class="email_address"><a href="mailto:ptontonoz@mednet.ucla.edu">ptontonoz@mednet.ucla.edu</a></p>
                <p>310-206-4546</p>
                <hr>
            </div>

            <div class="col-lg-2 ml-auto text-center">
                <p class="contact_name">Alan Saghatelian Ph.D.</p>
                <p>Professor</p>
                <p>Dr. Frederik Paulsen Chair</p>
                <p>Clayton Foundation Laboratories for Peptide Biology</p>
                <p>Salk Institute for Biological Studies</p>
                <p class="email_address"><a href="mailto:asaghatelian@salk.edu">asaghatelian@salk.edu</a></p>
                <p>858-453-4100</p>
                <hr>
            </div>

        </div>
    </div>
</section>
{{ end }}